Biological-E gets WHO nod to be additional facility for making Johnson Johnson COVID vaccine
India''s first indigenously developed RBD protein subunit vaccine, Biological E''s Corbevax, is currently being used to inoculate children in the age group of 12 to 14 years.
Biological-E gets WHO nod to be additional facility for making Johnson Johnson COVID vaccine
India''s first indigenously developed RBD protein subunit vaccine, Biological E''s Corbevax, is currently being used to inoculate children in the age group of 12 to 14 years.